Is Sunitinib a targeted drug?

Sunitinib(Sunitinib) is a type of targeted drug called a protein kinase inhibitor, which is a treatment for kidney cancer that has spread to other parts of the body(late stage or metastatic), a rare sarcoma called gastrointestinal stromal tumor (GIST), and pancreatic neuroendocrine tumor (pNET). Protein kinase is a chemical messenger (an enzyme) that plays a role in the growth of cancer cells. Sunitinib blocks protein kinases. It can stop tumor growth or shrink tumors.

Sunitinib usually comes in the form of capsules and can be swallowed whole once a day. For kidney cancer and gastrointestinal stromal tumors, sunitinib can be taken once a day for 4 weeks, and then stopped for 2 weeks. This 6-week period is called a treatment cycle. After 6 weeks the patient will start a new round of treatment. But some female patients may have menstrual cycles that last longer than 3 weeks, meaning they take sunitinib daily for 2 weeks followed by a week without treatment. Then start a new round of treatment, or possibly take a lower dose of sunitinib without interruption. As long as this treatment is effective and the side effects are not too severe, you can continue.

The original sunitinib drug has been launched in China and has entered the scope of Class B medical insurance. SpecificationsThe price of 12.5mg*28 tablets is around RMB 3,500. The original sunitinib drug has also been launched overseas. The price of 12.5mg*7 tablets is around RMB 1,500 (the price may fluctuate due to the exchange rate). There are also generic drugs produced in other countries. The price of 12.5mg*28 tablets produced by an Indian pharmaceutical factory is around RMB 750 (the price may fluctuate due to the exchange rate). The generic drugs produced abroad are basically the same as the original drugs at home and abroad. There may be differences in the prices of different specifications of drugs.